Bactiguard's AGM adopted resolutions on dividends, board and incentives
No dividend was paid, board and auditor re-elected, new incentive program approved, and share repurchase authorized.
See the latest news and media coverage for Bactiguard. We track all announcements, press releases, and industry mentions in real time, all in one place.
Coating technology for infection prevention on medical devices
bactiguard.comLast updated
In short: Bactiguard expanded its global partnership with BD, held its 2026 AGM, and reported a 25% revenue decline for the first quarter of 2026.
No dividend was paid, board and auditor re-elected, new incentive program approved, and share repurchase authorized.
Revenue decreases 25% to SEK 46.9 million. Operating loss is SEK 7.2 million. Adjusted EBITDA reaches SEK 4.9 million. CEO highlights partnerships and regulatory progress.
The AGM occurs on 19 May 2026 in Stockholm, covering reports, elections, incentives, and share authorizations.
The report is available at ir.bactiguard.com. During 2025, partnerships and profitability were strengthened through cost discipline for growth towards the 2030 goals.
Bactiguard Holding AB ( ($SE:BACTI.B) ) just unveiled an announcement. Bactiguard's Annual General Meeting approved the 2025 income statement and balance sheet ...
Bactiguard Holding AB (publ) today announces an update to its long standing collaboration with license partner BD (Becton, Dickinson & Company), a leading global medical...
Total revenue amounted to SEK 46.9 (62.7) million, a decrease of SEK 15.8 million corresponding to 25%. Net sales amounted to SEK 42.4 (59.1) million...
DNB Carnegie lowers the motivated value for the medical technology company Bactiguard to 18-27 kronor (26-45), according to a commissioned analysis. The revision reflects lowered estimates for sales during 2026...
Track Bactiguard and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.